Gumaed, Dindo L.

HRN: 28-69-49  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/15/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
03/15/2026
03/22/2026
IV
1.5gm
Q8
Mandibular Massnwith Pus Discharge
Remove - Pending Acceptance
03/15/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/15/2026
03/22/2026
IV
600mg
Q8
Mandibular Mass With Pus Discharge
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: